CN103330748A - Traditional Chinese medicine preparation used for treating facial paralysis and apoplexy sequela and preparation method of traditional Chinese medicine preparation - Google Patents
Traditional Chinese medicine preparation used for treating facial paralysis and apoplexy sequela and preparation method of traditional Chinese medicine preparation Download PDFInfo
- Publication number
- CN103330748A CN103330748A CN2013102962618A CN201310296261A CN103330748A CN 103330748 A CN103330748 A CN 103330748A CN 2013102962618 A CN2013102962618 A CN 2013102962618A CN 201310296261 A CN201310296261 A CN 201310296261A CN 103330748 A CN103330748 A CN 103330748A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- medicine preparation
- olibanum
- myrrha
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine preparation used for treating facial paralysis and an apoplexy sequela, and a preparation method of the traditional Chinese medicine preparation. The traditional Chinese medicine preparation comprises the following components in percentage by mass: 25%-31% of nux vomica preparata, 10.3%-16.6% of ephedra, 8%-11.1% of achyranthis bidentatae, 8.3%-11.1% of stiff silkworms, 5.6%-8.3% of rhizoma atractylodis, 6.9%-8.3% of frankincense, 5.6%-8.3% of scorpio, 6.9%-8.3% of myrrh and 8.3%-11.1% of liquorice. The traditional Chinese medicine preparation has effects of promoting blood circulation, dispersing blood stasis, expelling wind, removing cold, clearing and activating channels and collaterals, counteracting toxic substances, eliminating stagnation, and relieving swelling and pain, is mainly used for treating the apoplexy sequela, the facial paralysis, arthritis, scapulohumeral periarthritis, ischialgia, lumbar muscle degeneration, wind dampness arthralgia, amyotrophia and the like, and is good in healing effect.
Description
Technical field
The present invention relates to a kind of Chinese medicine preparation and preparation method thereof, especially a kind of Chinese medicine preparation that is used for the treatment of facial paralysis, apoplexy sequela and preparation method thereof, this Chinese medicine preparation also has significant curative effect to rheumatic Bi syndrome simultaneously.
Background technology
Apoplexy, facial paralysis and rheumatic arthralgia disease all are the obstinate diseases that causes because of the invasion and attack of having a cold, nearly 80% suffers from apoplexy, facial paralysis and rheumatic arthralgia disease in the crowd of China more than 50 years old, the method of existing treatment apoplexy and facial paralysis mostly is Western medicine and medicine for external use is main, and does not also occur for the Chinese medicine for oral administration of this obstinate disease of thorough treatment.
Summary of the invention
The purpose of this invention is to provide a kind of blood circulation promoting and blood stasis dispelling, expelling wind and cold, dredge the meridian passage, dispersing pathogen accumulation, reducing swelling and alleviating pain and especially can effectively treat Chinese medicine preparation of facial paralysis, apoplexy sequela and preparation method thereof, simultaneously, this Chinese medicine preparation also has significant curative effect to rheumatic Bi syndrome.
The present invention solves the technical scheme that the prior art problem adopts: a kind of Chinese medicine preparation that is used for the treatment of facial paralysis, apoplexy sequela, and the component of said preparation and quality percentage composition are as follows:
Semen Strychni (processed) 25%-31%; Herba Ephedrae 10.3%-16.6%;
Cattle sunset 8%-11.1%; Bombyx Batryticatus 8.3%-11.1%;
Rhizoma Atractylodis 5.6%-8.3%; Olibanum 6.9-8.3%;
Scorpio 5.6%-8.3% Myrrha 6.9%-8.3%
Radix Glycyrrhizae 8.3%-11.1%.
The quality percentage composition of each component is: Semen Strychni (processed) 25%, cattle sunset 8.3%, Rhizoma Atractylodis 8.3%, Herba Ephedrae 16.6%, Bombyx Batryticatus 8.3%, Scorpio 8.3%, Radix Glycyrrhizae 8.3%, Olibanum 8.3%, Myrrha 8.3%.
The quality percentage composition of each component is: Semen Strychni (processed) 27.7%, cattle sunset 11.1%, Rhizoma Atractylodis 5.6%, Herba Ephedrae 11.1%, Bombyx Batryticatus 11.1%, Scorpio 5.6%, Radix Glycyrrhizae 11.1%, Olibanum 8.3%, Myrrha 8.3%.
The quality percentage composition of each component is: Semen Strychni (processed) 31%, cattle sunset 10.3%, Rhizoma Atractylodis 6.9%, Herba Ephedrae 10.3%, Bombyx Batryticatus 10.3%, Scorpio 7.0%, Radix Glycyrrhizae 10.3%, Olibanum 6.9%, Myrrha 6.9%.
A kind of preparation method that is used for the treatment of the Chinese medicine preparation of facial paralysis, apoplexy sequela is characterized in that, may further comprise the steps:
(1) screening has been cut into slices and through fried Semen Strychni (processed), has been taken by weighing standby according to the quality percentage composition;
(2) take by weighing Niu Xi, Rhizoma Atractylodis, Herba Ephedrae, Bombyx Batryticatus, Scorpio, Radix Glycyrrhizae and mix and put into frying pan to fry yellowly standby, and avoid excessive parch;
(3) Olibanum and Myrrha are removed the oil that medicine itself contains, and the Olibanum after will deoiling, Myrrha are put cool standby.
(4) will mix through Semen Strychni (processed), Niu Xi, Rhizoma Atractylodis, Herba Ephedrae, Bombyx Batryticatus, Scorpio, Radix Glycyrrhizae, Olibanum and the Myrrha after the processing of step (1)-(3), pulverizing is 100 order fine powders and mixes thoroughly;
(5) described fine powder is packed into form capsule preparations in the Capsules.
When Olibanum and Myrrha are deoiled, Olibanum and Myrrha are fried in not containing watt container made of enamel coating till the non-foaming foam.
Beneficial effect of the present invention is: the present invention is the pure Chinese medicinal preparation for oral administration that is formed by configurations such as Semen Strychni (processed), Herba Ephedrae, Niu Xi, Bombyx Batryticatus, Rhizoma Atractylodis, Olibanum, Myrrhas.The present invention has the effect of blood circulation promoting and blood stasis dispelling, expelling wind and cold, dredge the meridian passage, dispersing pathogen accumulation, reducing swelling and alleviating pain.Be mainly used in treating multiple diseases such as apoplexy sequela, facial paralysis, arthritis, scapulohumeral periarthritis, sciatica, lumbar muscle strain, rheumatic arthralgia, amyotrophy, and curative effect is good.
The specific embodiment
The present invention will be described below in conjunction with the specific embodiment:
A kind of Chinese medicine preparation that is used for the treatment of facial paralysis, apoplexy sequela, the component of said preparation and quality percentage composition are as follows:
Semen Strychni (processed) 25%-31%; Herba Ephedrae 10.3%-16.6%;
Cattle sunset 8%-11.1%; Bombyx Batryticatus 8.3%-11.1%;
Rhizoma Atractylodis 5.6%-8.3%; Olibanum 6.9-8.3%;
Scorpio 5.6%-8.3%; Myrrha 6.9%-8.3%;
Radix Glycyrrhizae 8.3%-11.1%.
Below by preferred implementation the present invention is described further:
The present invention is divided into the treatment (table 1, table 2 shown in) of three kinds of dosage fully to satisfy the different syndromes patient:
Three kinds of preferred embodiments of each component percentage composition of table 1
| Each component percentage composition (%) | Semen Strychni (processed) | Niu Xi | Rhizoma Atractylodis | Herba Ephedrae | Bombyx Batryticatus | Scorpio | Radix Glycyrrhizae | Olibanum | Myrrha |
| Embodiment 1 | 25 | 8.3 | 8.3 | 16.6 | 8.3 | 8.3 | 8.3 | 8.3 | 8.3 |
| Embodiment 2 | 27.7 | 11.1 | 5.6 | 11.1 | 11.1 | 5.6 | 11.1 | 8.3 | 8.3 |
| Embodiment 3 | 31 | 10.3 | 6.9 | 10.3 | 10.3 | 7.0 | 10.3 | 6.9 | 6.9 |
Three kinds of preferred embodiments that corresponding tables 1 is listed, the concrete mass combination of each component that table 2 obtains for each the constituent mass percentage composition according to table 1.
Three kinds of preferred embodiments of each constituent mass content of table 2
| The quality of each component (g) | Semen Strychni (processed) | Niu Xi | Rhizoma Atractylodis | Herba Ephedrae | Bombyx Batryticatus | Scorpio | Radix Glycyrrhizae | Olibanum | Myrrha |
| Embodiment 1 | 150 | 50 | 50 | 100 | 50 | 50 | 50 | 50 | 50 |
| Embodiment 2 | 500 | 200 | 100 | 200 | 200 | 100 | 200 | 150 | 150 |
| Embodiment 3 | 900 | 300 | 200 | 300 | 300 | 200 | 300 | 200 | 200 |
Wherein, embodiment 1 is the general dose type, and the initial stage patient is preferably applied to take medicine;
Embodiment 2 is for strengthening dosage form, and the mid-term that is preferably applied to take medicine, improvement reach healing stage patient;
Embodiment 3 enters the consolidation phase patient for consolidating dosage form after being preferably applied to cure.
A kind of preparation method that is used for the treatment of the Chinese medicine preparation of facial paralysis, apoplexy sequela may further comprise the steps:
(1) screening has been cut into slices and through fried Semen Strychni (processed), has been taken by weighing standby according to the quality percentage composition;
(2) take by weighing Niu Xi, Rhizoma Atractylodis, Herba Ephedrae, Bombyx Batryticatus, Scorpio, Radix Glycyrrhizae and mix and put into frying pan to fry yellowly standby, and avoid excessive parch;
(3) Olibanum and Myrrha are removed the oil that medicine itself contains, and the Olibanum after will deoiling, Myrrha are put cool standby.When Olibanum and Myrrha are deoiled, Olibanum and Myrrha are fried in not containing watt container made of enamel coating till the non-foaming foam.
(4) will mix through Semen Strychni (processed), Niu Xi, Rhizoma Atractylodis, Herba Ephedrae, Bombyx Batryticatus, Scorpio, Radix Glycyrrhizae, Olibanum and the Myrrha after the processing of step (1)-(3), pulverizing is 100 order fine powders and mixes thoroughly;
(5) described fine powder is packed into form capsule preparations in the Capsules.
Usage and dosage of the present invention: once a day, sleep and took in preceding 30 minutes, take with yellow wine or boiled water.At the described three kinds of embodiment of table 2, the preparation of the 0.3-0.4g that packs in general every capsules, be grown up one time 6, increase by 2 every three days, increase to till 12, old people and 8-15 the year child in 4 rise and take, increase by 1 every three days, increase to till 10, one month is a course for the treatment of.
Use the points for attention of Chinese medicine preparation of the present invention:
(1) this is the normal reaction of medicine to take this medicine panhidrosis or neural twitch;
(2) raw meat, dish leaf, raw and cold food and Semen phaseoli radiati are eaten in the period in a medicine taboo;
(3) give birth to the skin ulcer body in the body big this medicine of taboo clothes more before that decreases not of the wound of breaking is arranged.
Through clinical treatment observation to facial paralysis patient medication 21 examples of 1 course for the treatment of in, 7 examples evident in efficacy, 2 examples that take a turn for the better, cure 12 examples, effective percentage reaches more than 90%, and 36 routine effective percentage of arthritis and scapulohumeral periarthritis are also reached 90%.
In sum, of the present inventionly can be used for treating facial paralysis apoplexy sequela and rheumatic arthralgia disease, its main feature is to utilize Semen Strychni (processed) and the Scorpio that contains certain toxicity, the Semen Strychni (processed) more than 30 percent that accounts for dose and Scorpio and selected several Chinese herbal medicine compatibilities in addition are in the same place, give full play to the effect of every medicine, the curative effect of performance treating the poisonous disease with poisonous drugs, allow and absorb fully in the body, capture pertinacious disease and break through the basic of pertinacious disease, begin treatment fundamentally, reparation have a cold meridians and the skeletal tissue of invasion and attack reach the purpose of rehabilitation body constitution.With rapid-action and remarkable stable curative effect healing is reached more than 90 percent.In case the patient occurs because of the phenomenon of carelessness overdose, the patient only need drink several mouthfuls of cold water just can be alleviated malaise symptoms and not have life danger in addition.In taking the process of preparation of the present invention, following outstanding performance and stability are arranged:
Performance one: cold expelling toxin expelling
Can occur the more than performance of panhidrosis after the patient takes medicine, and can feel and emit cold wind in the pore.This is because the cold in patient's body is the main inducement of morbidity, and can about day the cold in patient's body be discharged owing to the 15-20 that acts on of medicine itself after taking medicine of the present invention, begin treatment fundamentally reaches the toxin expelling effect of expelling wind and cold, diaphoresis cold expelling.
Performance two: dredge the meridian passage
Second outstanding behaviours facial paralysis patient after the patient takes medicine can feel that face has the blood streak, face is glossy, face nerve is understood rhythmical twitch or beat; The rheumatic arthralgia patient has and trembles in every limb, the symptom of leg joint and eldow ankylosis is shown effect repeatedly, and above-mentioned reaction all is the effect of dispersing pathogen accumulation of the present invention, dredge the meridian passage.This process is in the cold, to utilize the principle dredge the meridian passage for the treatment of the poisonous disease with poisonous drugs in discharging body, forces the effect of getting through blockage of main and collateral channels.
Performance three: the curative effect of characteristic symptom, rehabilitation is faster
Taking the 3rd outstanding behaviours of the present invention feels nervous for the facial paralysis patient can feel facial muscle, the patient of rheumatic arthralgia can feel that whole body joint and myalgia increase the weight of, symptoms such as dizziness and general weakness, this is that the present invention is the special efficacy that reaches healing, when pain increased the weight of about an about week, continue symptoms such as medication pain and numbness and fade away, recover normally at each position of whole body, thereby reach the effect of thorough healing.
Steadiness: consolidate curative effect, persistent ailment no longer recurs
When physical recovery is normal, after disease disappears, can continue to take course for the treatment of of the present invention, consolidate curative effect, pertinacious disease is not recurred, can strengthen simultaneously muscles and bones tough and tensile, strengthen muscle vitality and strengthen health gas, power etc., to reach the stability of curative effect.
According to clinical treatment experience, the patient with severe symptoms takes medicine and is no more than 4 courses for the treatment of and can cures, and general disease is taken medicine and is no more than 3 courses for the treatment of and can cures, and the patient of light symptom can take and be no more than 2 courses for the treatment of and can cure, and 2 to 3 times healing can be arranged and take medicine for the new trouble disease.
Above content be in conjunction with concrete optimal technical scheme to further describing that the present invention does, can not assert that concrete enforcement of the present invention is confined to these explanations.For the general technical staff of the technical field of the invention, without departing from the inventive concept of the premise, can also make some simple deduction or replace, all should be considered as belonging to protection scope of the present invention.
Claims (6)
1. a Chinese medicine preparation that is used for the treatment of facial paralysis, apoplexy sequela is characterized in that, the component of said preparation and quality percentage composition are as follows:
Semen Strychni (processed) 25%-31%; Herba Ephedrae 10.3%-16.6%;
Cattle sunset 8%-11.1%; Bombyx Batryticatus 8.3%-11.1%;
Rhizoma Atractylodis 5.6%-8.3%; Olibanum 6.9-8.3%;
Scorpio 5.6%-8.3%; Myrrha 6.9%-8.3%;
Radix Glycyrrhizae 8.3%-11.1%.
2. a kind of Chinese medicine preparation that is used for the treatment of facial paralysis, apoplexy sequela according to claim 1, it is characterized in that the quality percentage composition of each component is: Semen Strychni (processed) 25%, cattle sunset 8.3%, Rhizoma Atractylodis 8.3%, Herba Ephedrae 16.6%, Bombyx Batryticatus 8.3%, Scorpio 8.3%, Radix Glycyrrhizae 8.3%, Olibanum 8.3%, Myrrha 8.3%.
3. a kind of Chinese medicine preparation that is used for the treatment of facial paralysis, apoplexy sequela according to claim 1, it is characterized in that the quality percentage composition of each component is: Semen Strychni (processed) 27.7%, cattle sunset 11.1%, Rhizoma Atractylodis 5.6%, Herba Ephedrae 11.1%, Bombyx Batryticatus 11.1%, Scorpio 5.6%, Radix Glycyrrhizae 11.1%, Olibanum 8.3%, Myrrha 8.3%.
4. a kind of Chinese medicine preparation that is used for the treatment of facial paralysis, apoplexy sequela according to claim 1, it is characterized in that the quality percentage composition of each component is: Semen Strychni (processed) 31%, cattle sunset 10.3%, Rhizoma Atractylodis 6.9%, Herba Ephedrae 10.3%, Bombyx Batryticatus 10.3%, Scorpio 7.0%, Radix Glycyrrhizae 10.3%, Olibanum 6.9%, Myrrha 6.9%.
5. a kind of preparation method that is used for the treatment of the Chinese medicine preparation of facial paralysis, apoplexy sequela according to claim 1 is characterized in that, may further comprise the steps:
(1) screening has been cut into slices and through fried Semen Strychni (processed), has been taken by weighing standby according to the quality percentage composition;
(2) take by weighing Niu Xi, Rhizoma Atractylodis, Herba Ephedrae, Bombyx Batryticatus, Scorpio, Radix Glycyrrhizae and mix and put into frying pan to fry yellowly standby, and avoid excessive parch;
(3) Olibanum and Myrrha are removed the oil that medicine itself contains, and the Olibanum after will deoiling, Myrrha are put cool standby;
(4) will mix through Semen Strychni (processed), Niu Xi, Rhizoma Atractylodis, Herba Ephedrae, Bombyx Batryticatus, Scorpio, Radix Glycyrrhizae, Olibanum and the Myrrha after the processing of step (1)-(3), pulverizing is 100 order fine powders and mixes thoroughly;
(5) described fine powder is packed into form capsule preparations in the Capsules.
6. a kind of preparation method that is used for the treatment of the Chinese medicine preparation of facial paralysis, apoplexy sequela according to claim 5 is characterized in that, when Olibanum and Myrrha are deoiled, Olibanum and Myrrha is fried in not containing watt container made of enamel coating till the non-foaming foam.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2013102962618A CN103330748A (en) | 2013-07-16 | 2013-07-16 | Traditional Chinese medicine preparation used for treating facial paralysis and apoplexy sequela and preparation method of traditional Chinese medicine preparation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2013102962618A CN103330748A (en) | 2013-07-16 | 2013-07-16 | Traditional Chinese medicine preparation used for treating facial paralysis and apoplexy sequela and preparation method of traditional Chinese medicine preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103330748A true CN103330748A (en) | 2013-10-02 |
Family
ID=49238998
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2013102962618A Pending CN103330748A (en) | 2013-07-16 | 2013-07-16 | Traditional Chinese medicine preparation used for treating facial paralysis and apoplexy sequela and preparation method of traditional Chinese medicine preparation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103330748A (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104001118A (en) * | 2014-06-05 | 2014-08-27 | 陈龙霏 | Medicament for treating damp-heat spreading type motor neuron diseases and preparation method thereof |
| CN104027559A (en) * | 2014-05-28 | 2014-09-10 | 于恒峰 | Traditional Chinese medicine preparation for treating stroke sequela |
| CN104997862A (en) * | 2014-04-25 | 2015-10-28 | 代俊伟 | Rheumatism bone-curing medicine |
| CN110101738A (en) * | 2019-06-12 | 2019-08-09 | 张九海 | Bitong capsule for treating numbness and preparation method thereof |
| CN111067948A (en) * | 2020-01-15 | 2020-04-28 | 林红 | Traditional Chinese medicine composition for treating facial paralysis |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1338276A (en) * | 2001-06-16 | 2002-03-06 | 马金锋 | Medicine for treating cardiovascular and cerebrovascular diseases and diseases in nerve network system |
-
2013
- 2013-07-16 CN CN2013102962618A patent/CN103330748A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1338276A (en) * | 2001-06-16 | 2002-03-06 | 马金锋 | Medicine for treating cardiovascular and cerebrovascular diseases and diseases in nerve network system |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104997862A (en) * | 2014-04-25 | 2015-10-28 | 代俊伟 | Rheumatism bone-curing medicine |
| CN104027559A (en) * | 2014-05-28 | 2014-09-10 | 于恒峰 | Traditional Chinese medicine preparation for treating stroke sequela |
| CN104001118A (en) * | 2014-06-05 | 2014-08-27 | 陈龙霏 | Medicament for treating damp-heat spreading type motor neuron diseases and preparation method thereof |
| CN104001118B (en) * | 2014-06-05 | 2016-05-11 | 陈龙霏 | Be used for the treatment of medicine of damp and hot contamination type motor neuron disease and preparation method thereof |
| CN110101738A (en) * | 2019-06-12 | 2019-08-09 | 张九海 | Bitong capsule for treating numbness and preparation method thereof |
| CN111067948A (en) * | 2020-01-15 | 2020-04-28 | 林红 | Traditional Chinese medicine composition for treating facial paralysis |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102091234B (en) | Traditional Chinese medicine composition for treating bone fracture diseases | |
| CN103330748A (en) | Traditional Chinese medicine preparation used for treating facial paralysis and apoplexy sequela and preparation method of traditional Chinese medicine preparation | |
| CN104758690A (en) | Traditional Chinese medicinal preparation for treating pre-operative anesthesia and preparation method of traditional Chinese medicinal preparation | |
| CN102895365A (en) | External ointment for treating bone injury and orthopedics inflammation | |
| CN105362491A (en) | External-use medicine for treating cervical vertebra hyperosteogeny | |
| CN103893442A (en) | Traditional Chinese medicine medicament for treating rheumatic arthritis and preparation method thereof | |
| CN104623536A (en) | Chinese medicinal combination for treating insomnia | |
| CN104127728A (en) | Traditional Chinese medicine composition for treating traumatic bleeding | |
| CN101721479A (en) | Chinese herbal medicine preparation for treating rheumatalgia | |
| CN103623096B (en) | Hemiplegia xingnao zaizao pill and preparation method thereof | |
| CN103127349B (en) | Medicine for treating traumatic injury | |
| CN103989806B (en) | A kind of medicine for the treatment of osteoporosis and preparation method thereof | |
| CN103705761B (en) | Traditional Chinese medicine for treating cerebral hemorrhage diseases | |
| CN101485858B (en) | Application of Chinese herbal medicine hirudo in cerebrovascular disease | |
| CN103099889B (en) | Traditional Chinese medicine wine for treating lumbar spinal stenosis | |
| CN106265922A (en) | A kind of have bone strengthening and dehumidify the medicated wine of effect | |
| CN102018784A (en) | Pseudo-ginseng and safflower capsule for activating blood circulation and preparation method thereof | |
| CN106853193A (en) | It is a kind of to treat Chinese medicine of rheumatoid arthritis and preparation method thereof | |
| CN105233008A (en) | Traditional Chinese medicine composition for treating parkinson disease | |
| CN105168978B (en) | Expelling wind and clearing away cold, relaxing tendons and activating collaterals, the Chinese medicine composition of dissipating blood stasis and reducing the stagnation treatment muscles and bones arthralgia and its medicine bolus for recuperating and preparation method | |
| CN104740589A (en) | Traditional Chinese medicine preparation for treating skeletal fluorosis | |
| CN104083465A (en) | Medicinal liquor for treating sciatica and lumbar muscle strain and preparation method | |
| CN104173667A (en) | Traditional Chinese medicine composition for treating osteoarthritis | |
| CN103877216A (en) | Traditional Chinese medicine preparation for treating myocarditis and preparation method thereof | |
| CN114470087A (en) | External essence with special effect for treating neck, shoulder, waist and leg pain |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C05 | Deemed withdrawal (patent law before 1993) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20131002 |